Indeed, previous studies have demonstrated that MUC1 expression is associated with unfavorable outcomes, given its major oncogenic role in tumor progression [8,15,27], chemoresistance [8,9,10,28], and the establishment of an immunosuppressive microenvironment [18,29]. The gene discussed is MUC1; the disease is neoplasm.